Novo— 510(k) K212361

Substantially Equivalent

PathAI, Inc.

FDA 510(k) clearance K212361 for Novo, Substantially Equivalent on 2022-08-11. Applicant: PathAI, Inc..

Clearance details

Applicant: PathAI, Inc.
Product code: Code QKQ
Advisory panel: Pathology
Date received: 2021-07-30
Decision date: 2022-08-11
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Boston, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.